HIGHLIGHTS of THIS ISSUE This Listing Does Not Affect the Legal Status of Any Document Published in This Issue

Total Page:16

File Type:pdf, Size:1020Kb

HIGHLIGHTS of THIS ISSUE This Listing Does Not Affect the Legal Status of Any Document Published in This Issue FRIDAY, MAY 12, 1972 WASHINGTON, D.C. Volume 37 ■ Number 93 Pages 9539-9599 HIGHLIGHTS OF THIS ISSUE This listing does not affect the legal status of any document published in this issue. Detailed table of contents appears inside. PETROLEUM IMPORTS— Presidential proclama­ tion amends previous proclamation,........ ......... 9543 AIR QUALITY— EPA issues explanatory statement and adjusts sulfur oxide criteria as directed by Court of Appeals opinion in Kennecott case (2 documents)...................: ------------- 9577 CONTROLLED DRUGS— Justice Dept, publishes semiannual updating of lists..—............................. 9545 NATURAL GAS RATES— FPC suspends changes proposed by Amoco and begins hearing proce­ dures ........................................ 9587 MILITARY DRAFT— Selective Service proposed rules changes concerning appeals, conscientious objectors, and alternate service; comments with­ in 30 days.......................... ................... .............9566, 9567 I ADVERTISING PRACTICES— FTC 30-day notice of intent to close public record of recent hearing testimony ....................... 9591 SALMON IMPORTS— Customs Bureau eliminates some restrictions; effective 5 -1 2 -7 2 ........ 9560 ANTIDUMPING AND COUNTERVAILING DUTY— Treasury Dept, takes measures against Japanese wool fabrics, German tubeless tire valves, and Canadian steel belted tires (3 documents)........... 9568 30-year Reference Volumes Consolidated Indexes and Tables Presidential Proclamations and Executive Orders Consolidated subject indexes and tabular finding aids to Presidential proclamations, Executive orders, and certain other Presidential documents promulgated during a 30-year period (1936-1965) are now available in two separately bound volumes, published under Title 3 of the Code of Federal Regulations, priced as follows: Title 3, 1936-1965 Consolidated Indexes__________________________ $3. 50 Title 3, 1936-1965 Consolidated Tables- _________________________ $ 5 .2 5 Compiled by Office of the Federal Register, National Archives and Records Service, General Services Administration Order from Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 jests Published daily, Tuesday through Saturday (no publication on Sundays, Mondays, or on the day after an official Federal holiday), by the Office of the Federal Register, Nation« FEDERAL^pREGISTER Archives and Records Service, General Services Administration, Washington, D.O. 20408, Area Code 202 \ Phene 962-8626 pursuant to the authority contained in the Federal Register Act, approved July 26, 193» (49 Stat. 500, as amended; 44 U.S.C., Ch. 15), under regulations prescribed by the Administrative Committee of the Federal Register, ap­ proved by the President (1 CFR Ch. I)-. Distribution is made only by the Superintendent of Documents, U.S. Government Printing Office,, Washington, D.C. 20402. ' The F ederal R egister will be furnished by mail to subscribers, free of postage, for $2.50 per month or $25 per year, payable in advance. The charge for individual copies is 20 cents for each issue, or 20 cents for each group of pages as actually bound. Remit check or money order, made payable to the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402. The regulatory material appearing herein is keyed to the Code o f F ederal R egulations, which is published, under 50 titles, pursuant to section 11 of the Federal Register Act, as amended (44 U.S.C. 1510). The Code of F ederal R egulations is sold by the Superintenden of Documents. Prices of new books are listed in the first F ederal R egister issue of each month. There are no restrictions on the republication of material appearing in the F ederal R egister or the Code of F ederal regulations. Contents Notices FEDERAL POWER COMMISSION THE PRESIDENT Wool and polyester/wool worsted Rules and Regulations fabrics from Japan; withhold­ proclamation ing of appraisement notice----- 9568 Forms; exemption of small pro­ Modifying Proclamation 3279, re­ X-radial steel belted * tires from ducers from regulation; annual lating to imports of petroleum Canada; countervailing duties statem en t___ ___ 9559 and petroleum products----- — 9543 proceedings_________________• 9568 Notices Land withdrawn in certain proj­ EXECUTIVE AGENCIES DEFENSE DEPARTMENT ects; order vacating land With­ Notices drawals ______________ 1_____,. 9586 AGRICULTURAL MARKETING Deputy Secretary of Defense; del­ Hearings, etc.: egation of authority-------------- 9576 Amoco Production Co. et al___ . _ 9587 SERVICE Arkansas Power & Light Co_____ 9584 EMERGENCY PREPAREDNESS California Co. et al______ 9590 Rules and Regulations Cascade Natural Gas Corp— __ 9585 Papayas grown in Hawaii; ship­ OFFICE Detroit Edison Co____ ________ 9585 ments limitations---------------- - 9557 Notices Georgia Power Co_____ 1- 9585 Mobil Oil Corp______ 9586 Proposed Rule Making Appointments as Federal Coordi­ nating Officers: Oklahoma Natural Gas Gather­ Milk in upper Florida, Tampa Bay, Alfred Halm_______ _______ — 9591 ing Corp...__________ 9587 and southeastern Florida mar­ Leo McNamee----------. ------------- 9591 Public Utility District No. 1 of keting areas; hearing on tenta­ Chelan County_______ 9587 tive marketing agreements and EMPLOYMENT STANDARDS orders — i --------------- ■■------ —■?- 9565 FEDERAL TRADE COMMISSION Peaches grown in Georgia; han­ ADMINISTRATION dling limitations-------------------- 9564 Notices Notices Minimum wages for Federal and Modern advertising practices; no­ AGRICULTURE DEPARTMENT federally assisted construction; tice to close public record of area wage determination deci­ testimony and submissions of See Agricultural Marketing Serv­ data and views_______ __ ____ 9591 ice; Commodity Credit Corpor­ sions and modifications; new determinations______________ 9592 ation. HEALTH, EDUCATION, AND ENVIRONMENTAL PROTECTION ATOMIC ENERGY COMMISSION WELFARE DEPARTMENT AGENCY Notices Notices Notices Deputy Assistant Secretary for Boston Edison Co.; availability of Sulfur oxides: Administration; delegation of final environmental statement Air quality criteria----------------- - 9577 authority regarding appoint­ for Pilgrim Nuclear Power National secondary ambient air ment of Equal Opportunity Of­ Station ____________ 1------------ 9576 quality standards----------- -— 9577 ficer _______________------------- 9576 Omaha Public Power District; consideration of issuance of fa­ FEDERAL COMMUNICATIONS IMPORT PROGRAMS OFFICE cility operating license and op- _ portimity for hearing------------- 9576 COM MISSION Notices Rules and Regulations Duty-free entry of scientific ar­ CIVIL AERONAUTICS BOARD Frequency allocations; treaties ticles;' applications and deci­ and other international agree­ sions on applications: Notices ments relating to radio.----------- 9560 Catholic University of America. 9569 Hearings, etc.: Cornell University----------------- 9569 Automotive cargo investigation. 9577 Notices Harvard University et al---------- 9570 National Airlines, Inc________ 9577 Chicago Spectrum Management Massachusetts Institute of Region; requirements for filing Technology________________ 9571 COMMERCE DEPARTMENT application form in land mobile Pennsylvania State University services__ —------------------------- 9578 et al____ 9571 See Import Programs Office. Common carrier services informa­ State University of New York at tion ; domestic public radio serv^ Buffalo et al___ .____ 9572 COMMODITY CREDIT ices applications accepted for University of Califomia-San CORPORATION filin g________________ 9579 - Francisco and University of Standard broadcast stations; noti­ U ta h ____________________ 9573 Rules and Regulations fication lists: University of Illinois et al___ _ 9573 Flaxseed loan and purchase pro- Canada_____________________ 9583 Wayne State University---------- 9575 gram; 1972 crop__ _________ ._ 9558 Dominican Republic---------------- 9583 INTERSTATE COMMERCE CUSTOMS BUREAU FEDERAL MARITIME COMMISSION COM MISSION Rules and Regulations Notices Ports of entry; Peoria, 111.______ 9559 Notices Assignment of hearings------------- 9596 Special classes of merchandise; Certificates of financial responsi­ Motor carrier temporary authority elimination of certain restric­ bility (oil pollution) ; certifi­ applications------------------------- 9596 tions on importation of salmon. 9560 cates issued__________ 9584 Europe Canada Lakes Line ; agree­ JUSTICE DEPARTMENT Proposed Rule Making ment filed____________ 9583 See Narcotics and Dangerous Articles exported and returned; Gulf/Mediterranean Ports Con­ Drugs Bureau. duty-free entry of reimported ference Merchant’s Freight Con­ (Continued on next page) articles___ ________________ 9564 tract; petition filed— , ----------- 9583 9541 9542 CONTENTS LABOR DEPARTMENT SECURITIES AND EXCHANGE SMALL BUSINESS See Employment Standards Ad­ COMMISSION ADMINISTRATION ministration; O ccu p ation al Safety and Health Administra­ Notices Notices tion. Inter-Island Mortgagee Corp.; Central Investment Corporation order suspending trading.____ 9592 ‘of Denver; filing of application NARCOTICS AND DANGEROUS for approval of conflict * of DRUGS BUREAU SELECTIVE SERVICE SYSTEM interest transaction between as­ Rules and Regulations Proposed Rule Making sociates ______________ 9591 Surrender of licenses : Controlled substances; schedules, Alternate service._____________ 9567 Circle K Investment Corp_____ 9592 excluded nonnarcotic sub­ Conscientious objectors____ _____ 9566 Provident Enterprises Corp___ 9592 stances, and excepted stimulant or
Recommended publications
  • Isopropamide Iodide
    www.chemicalland21.com ISOPROPAMIDE IODIDE SYNONYMS (3-Carbamoyl-3,3-diphenylpropyl)diisopropylmethylammonium iodide; 2,2-Diphenyl-4- diisopropylaminobutyramide methiodide; 4-(Diisopropylamino)-2,2-diphenylbutyramide methiodide; gamma-(Aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-gamma-phenylbenzenepropanaminium iodide; Iodure d'isopropamide; Ioduro de isopropamida; Isopropamide ioduro; Isopropamidi iodidum; Isoproponum iodide; PRODUCT IDENTIFICATION CAS RN 71-81-8 EINECS RN 200-766-8 FORMULA C23H33IN2O MOL WEIGHT 480.43 PHYSICAL AND CHEMICAL PROPERTIES PHYSICAL STATE white to off-white powder MELTING POINT 199 C BOILING POINT DENSITY SOLUBILITY IN WATER pH VAPOR DENSITY REFRACTIVE INDEX FLASH POINT GENERAL DESCRIPTION Isopropamide is a long-acting anticholinergic and antimuscarinic drug of quaternary ammonium structure. It is used in the form of the iodide, (also bromide or chloride) to treat peptic ulcer and to suppress gastric secretion other gastrointestinal disorders. Brands of Isopropamide drugs: Darbid Dipramide Isamide Marygin-M Piaccamide Priamide Priazimide Sanulcin Tyrimide Quaternary ammonium anticholinergics (Synthetic) ATC Code Product CAS RN. A03AB01 Benzilonium bromide 1050-48-2 A03AB02 Glycopyrrolate 596-51-0 A03AB03 Oxyphenonium 14214-84-7 A03AB04 Penthienate 22064-27-3 A03AB05 Propantheline 50-34-0 A03AB06 Otilonium bromide 26095-59-0 A03AB07 Methantheline 5818-17-7 Please mail us if you want to sell your product or need to buy some products) www.chemicalland21.com ISOPROPAMIDE IODIDE A03AB08 Tridihexethyl 60-49-1 A03AB09 Isopropamide 7492-32-2 A03AB10 Hexocyclium 6004-98-4 A03AB11 Poldine 596-50-9 A03AB12 Mepenzolic acid 25990-43-6 A03AB13 Bevonium 33371-53-8 A03AB14 Pipenzolate 13473-38-6 A03AB15 Diphemanil methylsulfate 62-97-5 A03AB16 (2-Benzhydryloxyethyl)diethyl-methylammonium iodide A03AB17 Tiemonium iodide 144-12-7 A03AB18 Prifinium bromide 4630-95-9 A03AB19 Timepidium bromide 35035-05-3 A03AB21 Fenpiverinium bromide 125-60-0 03AB53 Oxyphenonium, combinations STABILITY AND REACTIVITY STABILITY Stable under normal conditions.
    [Show full text]
  • Muscarinic Acetylcholine Receptor
    mAChR Muscarinic acetylcholine receptor mAChRs (muscarinic acetylcholine receptors) are acetylcholine receptors that form G protein-receptor complexes in the cell membranes of certainneurons and other cells. They play several roles, including acting as the main end-receptor stimulated by acetylcholine released from postganglionic fibersin the parasympathetic nervous system. mAChRs are named as such because they are more sensitive to muscarine than to nicotine. Their counterparts are nicotinic acetylcholine receptors (nAChRs), receptor ion channels that are also important in the autonomic nervous system. Many drugs and other substances (for example pilocarpineand scopolamine) manipulate these two distinct receptors by acting as selective agonists or antagonists. Acetylcholine (ACh) is a neurotransmitter found extensively in the brain and the autonomic ganglia. www.MedChemExpress.com 1 mAChR Inhibitors & Modulators (+)-Cevimeline hydrochloride hemihydrate (-)-Cevimeline hydrochloride hemihydrate Cat. No.: HY-76772A Cat. No.: HY-76772B Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other… gastrointestinal, urinary, and reproductive systems and other… Purity: >98% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 1 mg, 5 mg 1 mg, 5 mg AC260584 Aclidinium Bromide Cat. No.: HY-100336 (LAS 34273; LAS-W 330) Cat.
    [Show full text]
  • The In¯Uence of Medication on Erectile Function
    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Wo 2010/075090 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 1 July 2010 (01.07.2010) WO 2010/075090 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07D 409/14 (2006.01) A61K 31/7028 (2006.01) kind of national protection available): AE, AG, AL, AM, C07D 409/12 (2006.01) A61P 11/06 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2009/068073 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 15 December 2009 (15.12.2009) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, (26) Publication Language: English TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/122,478 15 December 2008 (15.12.2008) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): AUS- ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, PEX PHARMACEUTICALS, INC.
    [Show full text]
  • Poisons Act.Fm
    LAWS OF BRUNEI CHAPTER 114 POISONS Enactment No. 13 of 1956 Amended by S 103/1958 Enactment No. 6 of 1967 S 101/1979 1984 Edition, Chapter 114 Amended by S 16/1996 S 28/2001 GN 273/2002 REVISED EDITION 2015 B.L.R.O. 1/2015 LAWS OF BRUNEI Poisons CAP. 114 1 LAWS OF BRUNEI REVISED EDITION 2015 CHAPTER 114 POISONS ARRANGEMENT OF SECTIONS Section 1. Citation. 2. Interpretation. 3. Description of poisons. 4. Licensing Officers. 5. General prohibition with respect to importation and sale of poisons. 6. Prohibitions and provisions relating to sale of poisons. 7. Exemptions in respect of medicines. 8. Exemptions in respect of sale. 9. Possession of poisons. 10. Issue of licences. 11. Different kinds of licence. 12. Licences to be numbered and registered. 13. Annual list to be published. 14. Forms of licence. 15. Search and search warrants. 16. Powers of exemption. 17. Penalties. B.L.R.O. 1/2015 LAWS OF BRUNEI 2 CAP. 114 Poisons 18. Jurisdiction. 19. Prosecutions. 20. Prohibition of sale to persons under 18. 21. Rules. SCHEDULE — POISONS LIST ____________________________ LAWS OF BRUNEI Poisons CAP. 114 3 POISONS ACT An Act to regulate the importation, possession, manufacture, compounding, storage, transport and sale of poisons Commencement: 1st January 1983 [S 61/1957] Citation. 1. This Act may be cited as the Poisons Act. Interpretation. 2. In this Act, unless the context otherwise requires — “dentist” means a dentist licensed under the Medical Practitioners and Dentists Act (Chapter 112) and includes a Government dentist; “export”, in relation
    [Show full text]
  • Experimental and Clinical Observations on Poldine In
    APRIL 15, 1961 MYOCARDIAL INFARCTION MBRrM 1071 Prognosis.-Our first patient is of interest because of the long survival period. A significant feature of septal EXPERIMENTAL AND CLINICAL perforation is that death does not occur immediately: OBSERVATIONS ON POLDINE IN Edmondson and Hoxie (1942) found an average period of survival of 7.4 days. In the series of Sanders et al. TREATMENT OF DUODENAL ULCER (1956) 13% (12 patients) lived from two months to BY several years. J. E. LENNARDiJONES, M.A., M.B., M.R.C.P. general principles of treatment are Treatment.-The Member, Medical Research Council Department of Clinical based on the knowledge that the efficiency of the heart Research, University College Hospital Medical School; in which septal perforation has occurred has already been Late Registrar, Department of Gastroenterology, Central impaired by coronary atherosclerosis followed by Middlesex Hospital, London myocardial infarction. The left-to-right shunt, with increased blood-flow and raised pressure in the The gastric secretion of acid by a patient with duodenal pulmonary circulation, throws an extra strain on the ulcer in response to a glucose test meal is about halved ventricles, and leads to heart failure. In our first two if an effective dose of poldine methosulphate (" nacton ") cases the administration of digitalis was of benefit, and is taken beforehand (Douthwaite and Hunt, 1958). The diuretics were of considerable help. In Case 1, after a drug also reduces gastric secretion of acid in response few weeks, there was a loss of response to mercurial to a large dose of histamine (R. Seidelin, 1960, personal diuretics: chlorothiazide with potassium supplements communication).
    [Show full text]
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
    [Show full text]
  • Pharmacy and Poisons Act 1979
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS ACT 1979 1979 : 26 TABLE OF CONTENTS PART I PRELIMINARY 1 Short title 2 Interpretation PART II THE PHARMACY COUNCIL 3 The Pharmacy Council 4 Membership of the Council 4A Functions of the Council 4B Protection from personal liability 4C Annual Report 5 Proceedings of the Council, etc PART III REGISTRATION OF PHARMACISTS 6 Offence to practise pharmacy if not registered 7 Registration as a pharmacist 7A Re-registration as non-practising member 7AA Period of validity of registration 8 Code of Conduct 9 Pharmacy Profession Complaints Committee 10 Investigation of complaint by Committee 10A Inquiry into complaint by Council 10B Inquiry by Council of its own initiative 11 Surrender of registration 12 Restoration of name to register 1 PHARMACY AND POISONS ACT 1979 13 Proof of registration 14 Appeals 14A Fees 14B Amendment of Seventh Schedule 15 Regulations for this part PART IV REGISTRATION OF PHARMACIES 16 Register of pharmacies 17 Registration of premises as registered pharmacies 18 Unfit premises: new applications 19 Unfit premises: registered pharmacies 20 Appeals 21 When certificates of unfitness take effect 22 Regulations for this Part PART V CONTROL OF PRESCRIPTIONS AND IMPORTATION 23 Prescriptions to be in a certain form 23A Validity of a prescription 24 Supply by registered pharmacist of equivalent medicines 25 Restrictions on the importation of medicines 26 Declaration relating to imported medicines [repealed] PART VI CONTROL OF DRUGS 27 Certain substances to be sold on prescription
    [Show full text]
  • Partial Agreement in the Social and Public Health Field
    COUNCIL OF EUROPE COMMITTEE OF MINISTERS (PARTIAL AGREEMENT IN THE SOCIAL AND PUBLIC HEALTH FIELD) RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies, and superseding Resolution AP (82) 2) AND APPENDIX I Alphabetical list of medicines adopted by the Public Health Committee (Partial Agreement) updated to 1 July 1988 APPENDIX II Pharmaco-therapeutic classification of medicines appearing in the alphabetical list in Appendix I updated to 1 July 1988 RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (superseding Resolution AP (82) 2) (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies) The Representatives on the Committee of Ministers of Belgium, France, the Federal Republic of Germany, Italy, Luxembourg, the Netherlands and the United Kingdom of Great Britain and Northern Ireland, these states being parties to the Partial Agreement in the social and public health field, and the Representatives of Austria, Denmark, Ireland, Spain and Switzerland, states which have participated in the public health activities carried out within the above-mentioned Partial Agreement since 1 October 1974, 2 April 1968, 23 September 1969, 21 April 1988 and 5 May 1964, respectively, Considering that the aim of the Council of Europe is to achieve greater unity between its members and that this
    [Show full text]
  • The Medical Treatment of Gastric and Duodenal Ulcer
    Postgrad. med. J. (August 1968) 44, 603-607. Postgrad Med J: first published as 10.1136/pgmj.44.514.603 on 1 August 1968. Downloaded from The medical treatment of gastric and duodenal ulcer M. J. S. LANGMAN Member of Scientific Staff, M.R.C. Statistical and Gastroenterological Research Units, University College Hospital, London, W.C. 1 THERAPY for gastric and duodenal ulceration has known association between peptic ulceration and in general been based upon rest, frequent meals, hepatic cirrhosis there is no evidence that moder- the avoidance of stress and potential irritants ate alcohol consumption has any real effect such as aspirin and smoking and the initiation upon ulcer incidence or prognosis. Finally no of treatment designed to reduce the corrosive specific dietary item has ever been convincingly quality of the gastric juice. Progress has however shown to be associated with liability to ulcera- been considerably hindered by our poor under- tion. standing of causal mechanisms. Medical treatment has in the past been largely Gastric ulcer tends to be associated with acid based upon the results reported by physicians hyposecretion and some degree of gastritis, while of their clinical experience obtained in uncon- in duodenal ulcer the parietal cell mass is usually trolled trials. Such results are however of little large and there is generally a high level of acid if any value because of the natural tendency for output. But it is not known if the gastric acid both gastric and duodenal ulcer to pursue a Protected by copyright. secretory capacity affects either the short-term remittent course with occasional exacerbations.
    [Show full text]